I'm looking
for help...
Aidpage is free!

Free downloads: GrantGate®  Federal Money Retriever®


Published on AidPage by IDILOGIC on Jun 24, 2005
Administered by:

Department of Health and Human Services, National Institutes of Health, National Institutes of Health
(see all US Federal Agencies)

Explore all postings for this grant program:
  • Original Grant - Oct 22, 2003
Applications Due:

Multiple Receipt Dates - See Link to Full Announcement for details.

total funding: Not Available
max award: none
min award: none
cost sharing, matching: No
number of awards: Not Available
type of funding: Cooperative Agreement

The intent of this solicitation is to invite applications from academic and
pharmaceutical industry investigators interested in participating with National
Institute of Mental Health (NIMH), the National Institute on Drug Abuse (NIDA), the
National Institute on Alcohol Abuse and Alcoholism (NIAAA), and the National Cancer
Institute in a National Cooperative Drug Discovery Group (NCDDG-MD/NA) Program to
accelerate innovative drug discovery, the development of pharmacologic tools for
basic and clinical research in mood disorders or nicotine addiction, and, in the
case of mood disorders, the development and validation of models for evaluating
novel therapeutics. NIMH, NIDA, NIAAA, and NCI are interested in jointly advancing
the discovery of new ligands because we anticipate that there are targets in common
and overlap in the expertise that can be brought to bear.

The goal of the NCDDG-MD/NA Program is to establish long-term partnerships between
NIH, academia, and industry that will advance the development and testing of new,
rationally based mechanism of action medications and treatments for mental
disorders and nicotine addiction.

Academic and/or pharmaceutical industry components of each NCDDG-MD/NA should
contribute unique scientific expertise towards the common goal of translating basic
science findings into innovative pharmacologic treatments for mental disorders and
drug addiction. Each partnership or group must consist of a multi-disciplinary
team of scientists with appropriate expertise to address the development and
evaluation of novel ligands, and the development of testing models where required.
Scientists from both academia and pharmaceutical industry are encouraged to
participate within an NCDDG-MD/NA. Scientists from foreign institutions and NIH
Intramural laboratories may participate in some aspects, as noted in other sections
of this application.

The NCDDG-MD/NA Program is most appropriate for applications that include
collaborations, Research Projects or core components from academia and the private
sector (e.g., pharmaceutical, chemical, or biotechnological companies). It is
anticipated that the interaction of academic and non-profit research institutions
with industry and NIH via the NCDDG-MD/NA model will: 1) accelerate the discovery
of new therapeutics for mood disorders and nicotine addiction; 2) increase the
availability of pharmacologic research tools for basic and clinical research; and
3) facilitate the development and validation of models to evaluate novel
therapeutics in mood disorders and nicotine addiction.

Small businesses without academic and/or industry partners are encouraged to
respond to parallel Program Announcements: Pharmacologic Agents and Drugs for
Mental Disorders (SBIR Award) [http://grants.nih.gov/grants/guide/pa-files/PA-02-
027.html], Competing Continuation Awards of SBIR Phase II Grants for Pharmacologic
Agents And Drugs for Mental Disorders [http://grants.nih.gov/grants/guide/pa-
files/PA-02-173.html], Development of PET and SPECT Ligands for Brain Imaging (SBIR
Award)[http://grants.nih.gov/grants/guide/pa-files/PA-02-028.html], and Innovative
Toxicology Models: SBIR/STTR - Addendum to PA-02-075, Notice NOT-MH-02-005

Who can apply:

Anyone/General Public
City Or Township Governments
County Governments
Federally Recognized Indian Tribal Governments
Independent School Districts
Minority Group
Native American Organization
Non-Government - General
Nonprofits Having A 501(C)(3) Status With The IRS, Other Than Institutions Of Higher Education
Nonprofits That Do Not Have A 501(C)(3) Status With The IRS, Other Than Institutions Of Higher Education
Other Private Institution/Organization
Private Institutions Of Higher Education
Private Nonprofit Institution/Organization (Includes Institutions Of Higher Education, Hospitals)
Profit Organization
Public And State Controlled Institutions Of Higher Education
Public Housing Authorities/Indian Housing Authorities
Small Business (Less Than 500 Employees
Special District Governments
State (Includes District Of Columbia; Includes Institutions Of Higher Education And Hospitals)
U.S. Territories And Possessions (Includes Institutions Of Higher Education, Hospitals)

Eligible functional categories:
Funding Sources:

Alcohol Research Programs
Cancer Cause and Prevention Research
Drug Abuse Research Programs
Mental Health Research Grants

More Information:


If you have problems accessing the full announcement, please contact: NIH OER Webmaster

Address Info:

Office of Extramural Programs
6705 Rockledge Drive
Bethesda, MD 20892-7963

Free downloads: GrantGate®  Federal Money Retriever®
Apply for grants and loans! Click here to start